The long-term prognosis of furosemide-associated nephrocalcinosis in t
he infant is still unclear, Although discontinuation of the diuretic o
ften results in radiological resolution of the calcifications, functio
nal abnormalities may persist. The natural history of the renal histop
athology of these patients is yet unknown. In the present study we inv
estigated the histological long-term outcome of furosemide-induced nep
hrocalcinosis in the young rat. Thirty-six weanling male Sprague-Dawle
y rats were divided into three groups: A controls, B furosemide given
for 8 weeks, and C furosemide given for 2 weeks followed by 6 weeks of
observation. Metabolic studies at the end of the experiment demonstra
ted a significant diuretic and natriuretic effect in group B. Kidney h
istology showed nephrocalcinosis scores (mean+/-SD) of 0.0+/-0.0 in A,
2.6+/-1.5 in B, and 0.8+/-0.6 in C, with B significantly higher than
A and C, and C greater than A. Kidney calcium content in B (3,421.9+/-
2,558.7 mu g/g dry tissue) was significantly greater than in A (310.4/-21.3) and C (1470.1+/-932.2). Another group of 6 rats receiving 2 we
eks treatment of furosemide showed a nephrocalcinosis score of 2.2+/-1
.5, not different from group B, and an additional group of 6 rats trea
ted with furosemide for 2 weeks and observed for another 12 weeks show
ed a score of 1.3+/-0.4, not different from group C. We conclude that
most of the renal calcifications induced by furosemide occur during th
e early days of treatment and that up to 12 weeks after discontinuatio
n of the diuretic, the resolution of the calcifications is only partia
l.